Proto Labs vs Xpel
Proto Labs and Xpel are similar in size: $533m and $476m of revenue in their latest fiscal years. Xpel grew faster (13.3% against 6.4%). Xpel kept more of each dollar of sales as profit: a net margin of 10.8% against 4.0%. Proto Labs carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | Proto LabsPRLB, 2025 | XpelXPEL, 2025 |
|---|---|---|
| Revenue | $533m | $476m |
| Revenue growth | 6.4% | 13.3% |
| Net income | $21.2m | $51.2m |
| Operating margin | 4.7% | 13.2% |
| Net margin | 4.0% | 10.8% |
| Return on equity | 3.2% | 20.3% |
| Free cash flow | $59.7m | $62.9m |
| Cash | $111m | $50.9m |
| Total debt | $0 | $59,000 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | $43.0m | $3.0m |
| Employees | 2,280 | 1,337 |
| Market value | $1.67bn | $1.17bn |
| Price vs our value range | Above our value range | Above our value range |
| Moat score | 60 (Moderate) | 74 (Strong) |
| Insider trades, 12 months | 0 buys, 15 sales | 0 buys, 0 sales |